Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA121205 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Affymetrix SNP array data for non-small cell lung cancer cell line samples, PC-9
| PRJNA121745 | ENA
Project description:Affymetrix SNP array data for lung cancer samples
| PRJNA266490 | ENA
Project description:In cancer, proto-oncogenes are often altered by genomic amplification. Recent studies have highlighted a role for PDGFRA as an oncogene in non-small cell lung cancer. To characterize 4q12 copy number status in NSCLC, both previously published (Weir et al. PMID 17982442) and unpublished Affymetrix 250K SNP array data for 733 NSCLC samples (628 primary samples, 105 cell lines) were evaluated for copy number aberrations. 4q12 amplifications overlapping the PDGFRA/KIT locus were observed in 31 (4.2%) NSCLC samples. SNP array and FISH analysis indicate that 4q12 is amplified in 3-7% of lung adenocarcinomas and 8-10% of lung squamous cell carcinomas. In addition, the NSCLC cell line NCI-H1703 exhibits focal amplification of PDGFRA and is dependent on PDGFRα activity for cell growth. Treatment of NCI-H1703 cells with PDGFRA-specific shRNAs or with the PDGFRα/KIT small molecule inhibitors imatinib or sunitinib leads to cell growth inhibition. However, these observations do not extend to NSCLC cell lines with lower-amplitude and broader gains of chromosome 4q. Together these observations implicate PDGFRA and KIT as potential oncogenes in NSCLC, but further study is needed to define the specific characteristics of those tumors that could respond to PDGFRα/KIT inhibitors.
2009-09-15 | GSE17429 | GEO
Project description:Affymetrix SNP array data for colon cancer samples
| PRJNA265875 | ENA
Project description:Affymetrix SNP array data for breast cancer samples
| PRJNA209971 | ENA
Project description:Affymetrix SNP array data for Ovarian Cancer Samples
| PRJNA291448 | ENA
Project description:Affymetrix SNP array data for Non-Smoking Female Lung Cancer in Taiwan
| PRJNA154251 | ENA
Project description:East-Asian (EA) patients with Non Small Cell Lung Cancer (NSCLC) are associated with a high proportion of non-smoking women, EGFR activating somatic mutations, and clinical responses to tyrosine kinase inhibitors. We identify copy number alterations specific to EA and Western European (WE) NSCLCs and conducted an integrative analysis using transcritomic data for identifying copy-number-driven candidate genes. Samples were hybridized to Affymetrix Genome-Wide Human SNP 6.0 arrays according to the manufacturer’s specifications in the same center.
2011-11-22 | GSE33848 | GEO
Project description:Affymetrix SNP array data for rhabdomyosarcoma samples
| PRJNA269634 | ENA